+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Injury Treatment Market - Global Forecast 2025-2030- Product Image
Vascular Injury Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Vascular Injury Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986092
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vascular injury treatment market is undergoing significant transformation as advanced medical technologies, minimally invasive procedures, and strategic collaborations converge to address complex clinical challenges. Senior decision-makers must remain attuned to evolving market drivers, regulatory shifts, and innovation pipelines to navigate this dynamic environment and capture sustainable value.

Market Snapshot – Vascular Injury Treatment Market Outlook

The Vascular Injury Treatment Market grew from USD 24.45 billion in 2024 to USD 27.92 billion in 2025. It is expected to continue growing at a CAGR of 13.80%, reaching USD 53.12 billion by 2030. This sustained growth underscores rising clinical demand for advanced interventions, propelled by greater adoption of technology-enhanced devices and a robust innovation pipeline across global regions. Expansion reflects the collective impact of research advances, streamlined care workflows, and a movement toward patient-centric therapeutic models.

Scope & Segmentation

This report thoroughly analyzes the vascular injury treatment sector across product, modality, end-user, injury type, and regional spectrums, highlighting technological advances and critical market segments:

  • Product Types: Catheters, Embolic Protection Devices, Stents, Thrombolytic Drugs, and Vascular Grafts.
  • Catheters: Aspiration, Balloon, and Delivery Catheters shaping access solutions for various interventions.
  • Embolic Protection Devices: Distal Filters and Proximal Occlusion Devices used to reduce procedural risks.
  • Stents: Bare Metal, Covered, and Drug-Eluting Stents provide mechanical integrity with or without drug delivery functionality.
  • Thrombolytic Drugs: Streptokinase, Tissue Plasminogen Activator, and Urokinase address acute vascular occlusions.
  • Vascular Grafts: Biological and Synthetic Grafts restore vessel structure and function.
  • Treatment Modalities: Endovascular Repair (inclusive of Aortic, Carotid, and Peripheral Stenting), Open Surgery, and Pharmacotherapy.
  • End Users: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics remain key care delivery settings.
  • Injury Types: Arterial, Capillary, Microvascular, and Venous Injuries, addressing the spectrum of vascular traumas.
  • Regions Covered: Americas (including U.S. states such as California and New York), Europe, Middle East & Africa (inclusive of major countries like Germany and UAE), Asia-Pacific (including China, India, and Australia).
  • Featured Companies: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, W. L. Gore & Associates, Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, and Edwards Lifesciences Corporation.

Key Takeaways

  • The vascular injury treatment landscape is rapidly evolving due to integration of sophisticated imaging modalities and personalization of therapeutic strategies.
  • Technological advancements in catheters and embolic protection devices are enabling less invasive approaches and reducing perioperative risks.
  • Data-driven approaches and AI-supported diagnostics are increasingly influencing device selection and clinical decision-making.
  • Regional growth is shaped by infrastructure investments, government incentives, and the emergence of local manufacturing capacities in diverse markets.
  • Regulatory harmonization and value-based healthcare models are facilitating accelerated adoption of innovative solutions while aligning stakeholder incentives.
  • Strategic collaborations, such as alliances with contract research organizations and academic centers, are streamlining clinical trials and expediting market entry for next-generation devices.

Tariff Impact

Upcoming United States tariff adjustments are set to alter cost structures and supply chain strategies for vascular injury treatment providers. Manufacturers are now exploring diversified supplier networks, in-country production, and long-term procurement contracts to mitigate price volatility. These shifts prompt a need for operational agility, tailored financial approaches, and close supplier partnerships to preserve innovation momentum and maintain clinical excellence despite evolving tariff pressures.

Methodology & Data Sources

Findings are based on a rigorous research framework combining primary interviews with interventional radiologists, vascular surgeons, and procurement specialists, along with review of peer-reviewed publications and regulatory filings. Supplementary analysis of government databases and industry reports validated the data. Expert panels ensured synthesis accuracy and methodological robustness throughout the research process.

Why This Report Matters

  • Uncovers actionable insights on emerging technologies and target market segments for precise strategic planning.
  • Enables alignment of R&D, procurement, and partnership priorities with the latest regulatory and economic factors impacting the vascular injury treatment landscape.
  • Supports decision-makers in benchmarking against top competitors and identifying high-growth geographies and therapeutic opportunities.

Conclusion

Senior leaders equipped with this report are positioned to anticipate disruption, foster collaborative networks, and make informed decisions that drive competitive advantage in vascular injury treatment. Market progress hinges on innovation, strategic foresight, and effective stakeholder engagement for optimal patient care and organizational performance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding applications of drug eluting balloons for complex peripheral vascular injury management
5.2. Surge in endovascular robotic assistance systems improving precision in trauma induced injuries
5.3. Development of multifunctional hemostatic dressings integrating nanoparticles for rapid bleeding control
5.4. Adoption of AI driven predictive analytics for optimizing treatment pathways in vascular trauma patients
5.5. Growth in minimally invasive percutaneous mechanical thrombectomy devices for arterial injury repair
5.6. Increasing collaboration between biotech firms and academic centers for regenerative vascular therapies
5.7. Rise of 3D printed customizable vascular grafts enhancing compatibility in complex injuries
5.8. Enhanced focus on hemodynamic monitoring technologies to improve outcomes in vascular trauma
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Injury Treatment Market, by Product
8.1. Introduction
8.2. Catheters
8.2.1. Aspiration Catheters
8.2.2. Balloon Catheters
8.2.3. Delivery Catheters
8.3. Embolic Protection Devices
8.3.1. Distal Filters
8.3.2. Proximal Occlusion Devices
8.4. Stents
8.4.1. Bare Metal Stents
8.4.2. Covered Stents
8.4.3. Drug Eluting Stents
8.5. Thrombolytic Drugs
8.5.1. Streptokinase
8.5.2. Tissue Plasminogen Activator
8.5.3. Urokinase
8.6. Vascular Grafts
8.6.1. Biological Grafts
8.6.2. Synthetic Grafts
9. Vascular Injury Treatment Market, by Treatment Modalities
9.1. Introduction
9.2. Endovascular Repair
9.2.1. Aortic Stenting
9.2.2. Carotid Stenting
9.2.3. Peripheral Stenting
9.3. Open Surgery
9.4. Pharmacotherapy
9.4.1. Anticoagulants
9.4.2. Antiplatelet Drugs
9.4.3. Thrombolytics
10. Vascular Injury Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Vascular Injury Treatment Market, by Injury Type
11.1. Introduction
11.2. Arterial Injury
11.3. Capillary Injury
11.4. Microvascular Injury
11.5. Venous Injury
12. Americas Vascular Injury Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vascular Injury Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vascular Injury Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Boston Scientific Corporation
15.3.4. Johnson & Johnson
15.3.5. W. L. Gore & Associates, Inc.
15.3.6. Terumo Corporation
15.3.7. B. Braun Melsungen AG
15.3.8. Becton, Dickinson and Company
15.3.9. Teleflex Incorporated
15.3.10. Edwards Lifesciences Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VASCULAR INJURY TREATMENT MARKET: RESEARCHAI
FIGURE 24. VASCULAR INJURY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. VASCULAR INJURY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. VASCULAR INJURY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 148. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 149. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 150. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 151. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 152. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 153. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 154. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 155. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 156. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 157. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 158. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 159. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 160. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 161. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 162. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 163. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 164. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 165. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 184. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 185. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2024 (USD MILLION)
TABLE 296. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2025-2030 (USD MILLION)
TABLE 297. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 298. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 299. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 304. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 305. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 306. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 307. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 308. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 309. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 310. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 312. FRANCE VASCULAR INJURY TREATMENT MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 27.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 53.12 Billion
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Interventional Cardiology and Peripheral Vascular Devices Market 2025-2033 - Product Image

Interventional Cardiology and Peripheral Vascular Devices Market 2025-2033

  • Report
  • 145 Pages
  • Global
From
Cardiovascular Repair and Reconstruction Devices Market Report and Forecast 2025-2034 - Product Image

Cardiovascular Repair and Reconstruction Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030 - Product Image

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • United States
From

About the Vascular Injury Treatment Market

The Vascular Injury Treatment market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. It includes a variety of products and services designed to treat vascular injuries, such as endovascular stents, embolic protection devices, and vascular closure devices. These products are used to treat a variety of conditions, including peripheral artery disease, stroke, and aneurysms. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. Additionally, the rising geriatric population and the increasing awareness of vascular injury treatments are expected to drive the market growth. Some of the major companies in the Vascular Injury Treatment market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Johnson & Johnson, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.